Search results for "FLORA"

showing 10 items of 989 documents

Birth Mode-Related Differences in Gut Microbiota Colonization and Immune System Development.

2018

<b><i>Background:</i></b> The process of early gut colonization is extremely variable among individuals and is influenced by numerous factors. Among these, the mode of birth will strongly shape the early microbial exposure and immune environment of the neonate. <b><i>Summary:</i></b> Here, I review how the concomitant processes of microbiota and immune system development are altered by C-section delivery and the effects of such alterations on long-term health. <b><i>Key messages:</i></b> C-section delivery impinges on microbiota and immune system development through various means: (i) if labor is lacking, intrauterine i…

0301 basic medicineAllergyMedicine (miscellaneous)DiseaseBiologyGut flora03 medical and health sciencesFecesImmune systemTime windowsPregnancymedicineHumansColonizationGut colonizationNutrition and DieteticsCesarean SectionInfant Newbornbiochemical phenomena metabolism and nutritionmedicine.diseasebiology.organism_classificationDelivery ObstetricGastrointestinal Microbiome030104 developmental biologyImmune SystemImmunologyVaginabacteriaFemaleAnnals of nutritionmetabolism
researchProduct

Potential probiotic salami with dietary fiber modulates metabolism and gut microbiota in a human intervention study

2020

A human intervention in 24 healthy volunteers was performed to test the potential health benefits of a fermented salami with a probiotic Lactobacillus rhamnosus HN001 and added citrus fiber. Anthropometric measurements and blood biochemistry did not show any significant differences between pre- and post-intervention during 4 weeks with a daily intake of 30 g of salami, neither with regular salami (control group) nor with reformulated salami (intervention group). However, the inflammatory markers CRP and TNFα decreased significantly after intervention, suggesting a less inflammatory environment after reformulated salami consumption. Antioxidant plasmatic markers also improved within the inte…

0301 basic medicineAntioxidantConsumptionmedicine.medical_treatmentMedicine (miscellaneous)ButyrateGut microbiotaGut floraSalamiProbioticLactobacillus-rhamnosus hn001law.invention03 medical and health sciencesProbiotic0404 agricultural biotechnologyLactobacillus rhamnosuslawmedicineTX341-641Food science030109 nutrition & dieteticsNutrition and Dieteticsbiologybusiness.industryNutrition. Foods and food supplyCitrus fiberShort chain fatty acids04 agricultural and veterinary sciencesMetabolismbiology.organism_classification040401 food scienceIntervention studiesAntioxidant capacityDietary fiberbusinessMeat-productsFood Science
researchProduct

Involvement of Gut Microbiota, Microbial Metabolites and Interaction with Polyphenol in Host Immunometabolism

2020

Immunological and metabolic processes are inextricably linked and important for maintaining tissue and organismal health. Manipulation of cellular metabolism could be beneficial to immunity and prevent metabolic and degenerative diseases including obesity, diabetes, and cancer. Maintenance of a normal metabolism depends on symbiotic consortium of gut microbes. Gut microbiota contributes to certain xenobiotic metabolisms and bioactive metabolites production. Gut microbiota-derived metabolites have been shown to be involved in inflammatory activation of macrophages and contribute to metabolic diseases. Recent studies have focused on how nutrients affect immunometabolism. Polyphenols, the seco…

0301 basic medicineAntioxidantmedicine.medical_treatmentAnti-Inflammatory Agentslcsh:TX341-641InflammationReviewGut florametabolic diseasesdigestive systemAntioxidants03 medical and health scienceschemistry.chemical_compound0302 clinical medicineImmunitymedicineHumansSymbiosismetabolitesInflammationNutrition and DieteticsCellular metabolismHost Microbial Interactionsgut microbiotabiologyHost (biology)MacrophagesPolyphenolsfood and beveragesbiology.organism_classificationGastrointestinal Microbiomepolyphenol030104 developmental biologyBiochemistrychemistryPolyphenol030220 oncology & carcinogenesisChronic DiseaseDietary Supplementsmedicine.symptomXenobioticlcsh:Nutrition. Foods and food supplyFood ScienceNutrients
researchProduct

Potential benefits of high-added-value compounds from aquaculture and fish side streams on human gut microbiota

2021

Background: Human gut microbiota dysbiosis has been linked to a higher risk of non-communicable diseases (NCDs) such us inflammatory disorders, allergy and obesity. Specific dietary strategies, including the use of specific food supplements targeted to microbiota modulation, have been suggested to be especially relevant in reducing the risk of NCDs. In this regard, marine environment is considered as a pivotal source of nutrients and bioactive compounds such as polyunsaturated fatty acids, polysaccharides and active peptides. These compounds, including algae- (alginate, fucoidan) and animal-derived polysaccharides (chitin, chitosan), among others, have been widely studied. The use of these …

0301 basic medicineAquatic lifeGut microbiotaGut floraFats03 medical and health sciencesHuman healthHuman gutAquaculturePolysaccharidesmedicineFood science2. Zero hungerchemistry.chemical_classification030109 nutrition & dieteticsbiologybusiness.industryProteinmedicine.diseasebiology.organism_classification3. Good healthSide streams030104 developmental biologychemistry13. Climate actionFish <Actinopterygii>businessDysbiosisFood ScienceBiotechnologyPolyunsaturated fatty acid
researchProduct

Gut Microbiota, Short-Chain Fatty Acids, and Herbal Medicines

2018

As an important source for traditional medical systems such as Ayurvedic medicine and traditional Chinese medicine, herbal medicines have received widespread attentions from all over the world, especially in developing countries. Over the past decade, studies on gut microbiota have generated rich information for understanding how gut microbiota shape the functioning of our body system. In view of the importance of gut microbiota, the researchers engaged in studying herbal medicines have paid more and more attention to gut microbiota and gut microbiota metabolites. Among a variety of gut microbiota metabolites, short-chain fatty acids (SCFAs) have received most attention because of their imp…

0301 basic medicineBody systemPharmacologyAyurvedic medicineTraditional medicinegut microbiotaMini Reviewshort-chain fatty acidslcsh:RM1-950Traditional Chinese medicineBiologyGut florabiology.organism_classificationdigestive system03 medical and health sciencestraditional Chinese medicine030104 developmental biologylcsh:Therapeutics. Pharmacologyherbal medicinesPharmacology (medical)metabolitesMedical systemsFrontiers in Pharmacology
researchProduct

Gut Microbiota Condition the Therapeutic Efficacy of Trastuzumab in HER2-Positive Breast Cancer.

2021

Abstract Emerging evidence indicates that gut microbiota affect the response to anticancer therapies by modulating the host immune system. In this study, we investigated the impact of gut microbiota on immune-mediated trastuzumab antitumor efficacy in preclinical models of HER2-positive breast cancer and in 24 patients with primary HER2-positive breast cancer undergoing trastuzumab-containing neoadjuvant treatment. In mice, the antitumor activity of trastuzumab was impaired by antibiotic administration or fecal microbiota transplantation from antibiotic-treated donors. Modulation of the intestinal microbiota was reflected in tumors by impaired recruitment of CD4+ T cells and granzyme B–posi…

0301 basic medicineCD4-Positive T-LymphocytesCancer ResearchReceptor ErbB-2medicine.medical_treatmentGut floraGranzymesMice0302 clinical medicineAntineoplastic Agents ImmunologicalTrastuzumabTumor Microenvironmentskin and connective tissue diseasesNeoadjuvant therapybiologyFecal Microbiota TransplantationInterleukin-12Neoadjuvant TherapyAnti-Bacterial AgentsTreatment OutcomeOncology030220 oncology & carcinogenesisStreptomycinCytokinesGut microbiota trastuzumab breast cancerFemaleTaxoidsmedicine.drugBridged-Ring CompoundsBreast NeoplasmsSettore MED/08 - Anatomia PatologicaNitric Oxide03 medical and health sciencesImmune systemBreast cancerVancomycinmedicineAnimalsHumansCyclophosphamideImmunity Mucosalbusiness.industryLachnospiraceaeDendritic cellDendritic CellsTrastuzumabbiology.organism_classificationmedicine.diseaseGastrointestinal Microbiome030104 developmental biologyGranzymeDoxorubicinImmune Systembiology.proteinCancer researchInterferonsbusinessCancer research
researchProduct

Impact of plant sterols enrichment dose on gut microbiota from lean and obese subjects using TIM-2 in vitro fermentation model

2019

There are scarce data on plant sterols (PS) and gut microbiota relationship. The purpose of this study is to compare the interaction between PS and gut microbiota through in vitro colonic fermentation studies using a validated system (TIM-2) with a PS-enriched dose (similar to 2 g/day) from two sources (food PS-source ingredient and commercial standard) using microbiota from lean and obese populations. Fecal sterols, short chain fatty acids (SCFA) and microbiota composition were determined by GC/MS, IEC, and 16S-sequencing, respectively.PS-feeding decreased coprostanol and ethylcoprostanol concentration and increased the production of acetate and butyrate (mainly with lean microbiota). In a…

0301 basic medicineCHROMATOGRAPHYMedicine (miscellaneous)ButyrateGut microbiotaGut floradigestive systemPlant sterolsNEUTRAL STEROLS03 medical and health sciencesIngredientchemistry.chemical_compoundBUTYRATE0404 agricultural biotechnologyfluids and secretionsTX341-641Food scienceFecesBILE-ACIDS030109 nutrition & dieteticsNutrition and DieteticsbiologyPHYTOSTEROLSCholesterolNutrition. Foods and food supplyCHOLESTEROLHUMANSShort chain fatty acids04 agricultural and veterinary sciencesbiology.organism_classificationCANCER040401 food scienceIn vitroPRODUCTSCoprostanolCHAIN FATTY-ACIDSchemistryFermentationTIM-2 in vitro modelFecal sterolsFood ScienceJournal of Functional Foods
researchProduct

Integrating the Tumor Microenvironment into Cancer Therapy

2020

© 2020 by the authors.

0301 basic medicineCancer ResearchMechanotransductionReviewGut floralcsh:RC254-28203 medical and health sciences0302 clinical medicineImmune systemStromamedicineMechanotransductionStromal reprogrammingTumor microenvironmentbiologybusiness.industryMicrobiotaCancerlcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.diseasebiology.organism_classificationPrognostic toolsMetforminMitochondria030104 developmental biologyMetabolismOncologyImmune therapyTumor progression030220 oncology & carcinogenesisCancer researchBiomarker discoverybusinessReprogrammingVitamin D3
researchProduct

2019

Colorectal cancer (CRC) and cachexia are associated with the gut microbiota and microbial surface molecules. We characterized the CRC-associated microbiota and investigated whether cachexia affects the microbiota composition. Further, we examined the possible relationship between the microbial surface molecule flagellin and CRC. CRC cells (C26) were inoculated into mice. Activin receptor (ACVR) ligands were blocked, either before tumor formation or before and after, to increase muscle mass and prevent muscle loss. The effects of flagellin on C26-cells were studied in vitro. The occurrence of similar phenomena were studied in murine and human tumors. Cancer modulated the gut microbiota witho…

0301 basic medicineCancer ResearchTumor microenvironmentbiologyCancerInflammationActivin receptorMyostatinGut florabiology.organism_classificationmedicine.disease3. Good healthCachexia03 medical and health sciences030104 developmental biology0302 clinical medicineOncology030220 oncology & carcinogenesismedicineCancer researchbiology.proteinmedicine.symptomFlagellinCancers
researchProduct

Analysis of the Gut Microbiota: An Emerging Source of Biomarkers for Immune Checkpoint Blockade Therapy in Non-Small Cell Lung Cancer

2021

Simple Summary The immune checkpoint blockade (ICB), and concretely the blockade of the PD1/PDL1 axis, has opened up a new standard of treatment for non-small cell lung cancer (NSCLC). However, despite substantial advances in clinical care, many patients still remain refractory to these therapies. Biomarkers such as PD-L1 expression and tumor mutational burden have been associated with ICB efficacy, but the mechanisms underlying variable responses are not yet fully understood. Recently, the differential composition of the gut microbiota was studied as one of the variables accounting for interpatient heterogeneity in ICB responses. To better understand the potential role of the gut microbiot…

0301 basic medicineCancer Researchmedicine.drug_classmedicine.medical_treatmentAntibioticsGut floradigestive systemArticle03 medical and health sciences0302 clinical medicinemedicineLung cancerRC254-282non-small cell lung cancerbiologygut microbiotabusiness.industryNeoplasms. Tumors. Oncology. Including cancer and carcinogensImmunotherapyimmune checkpoint blockademedicine.diseasebiology.organism_classificationImmune checkpointBlockade030104 developmental biologyOncology030220 oncology & carcinogenesisImmunologyBiomarker (medicine)biomarkernext-generation sequencingimmunotherapybusinessProgressive disease
researchProduct